These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8841595)

  • 1. Binding affinity of N3-substituted uridine for synaptic membrane and their CNS depressant effects.
    Kimura T; Miki M; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1995; (34):147-8. PubMed ID: 8841595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedative and hypnotic activities of pyrimidine nucleoside derivatives.
    Kimura T; Teraoka S; Kuze J; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1993; (29):51-2. PubMed ID: 8247791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nucleoside derivatives possessing sedative and hypnotic effects.
    Kimura T; Kuze J; Watanabe K; Yamamoto I; Ueda T; Katagiri N; Kaneko C; Tateoka Y; Kondo S
    Nucleic Acids Symp Ser; 1991; (25):95-6. PubMed ID: 1842113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uridine receptor: discovery and its involvement in sleep mechanism.
    Kimura T; Ho IK; Yamamoto I
    Sleep; 2001 May; 24(3):251-60. PubMed ID: 11322706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of N3-substituted uridine and related pyrimidine nucleosides and their antinociceptive effects in mice.
    Shimizu T; Kimura T; Funahashi T; Watanabe K; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 2005 Mar; 53(3):313-8. PubMed ID: 15744105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N3-phenacyluridine, a novel hypnotic compound, interacts with the benzodiazepine receptor.
    Kimura T; Kuze J; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Eur J Pharmacol; 1996 Sep; 311(2-3):265-9. PubMed ID: 8891608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of a novel hypnotic, N3-phenacyluridine, and hypnotic and sedative activities of its enantiomer metabolites in mouse.
    Kimura T; Miki M; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Xenobiotica; 2000 Jun; 30(6):643-53. PubMed ID: 10923865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro metabolic studies of N3-benzyluridine which exhibits hypnotic activity in mice.
    Kimura T; Yamamoto I; Watanabe K; Tateoka Y; Ho IK
    Res Commun Chem Pathol Pharmacol; 1991 Jan; 71(1):27-48. PubMed ID: 2024063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-substituted oxopyrimidines and nucleosides: structure-activity relationship for hypnotic activity as central nervous system depressant.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    J Med Chem; 1987 Dec; 30(12):2227-31. PubMed ID: 3681892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system depressant effects of N3-substituted derivatives of deoxyuridine in mice.
    Kimura T; Kuze J; Teraoka S; Watanabe K; Tateoka Y; Kondo S; Ho IK; Yamamoto I
    Biol Pharm Bull; 1996 Jan; 19(1):142-5. PubMed ID: 8820928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 6-azauridine analogues possessing sedative and hypnotic effects.
    Kimura T; Watanabe K; Koshigami M; Miyamoto K; Kondo S; Yamamoto I
    Nucleic Acids Symp Ser; 1992; (27):199-200. PubMed ID: 1283907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potent depressant effects of N3-phenacyluridine in mice.
    Yamamoto I; Kuze J; Kimura T; Watanabe K; Kondo S; Ho IK
    Biol Pharm Bull; 1994 Apr; 17(4):514-6. PubMed ID: 8069259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypnotic activities of N3-benzyl and xylyl substituted arabinofuranosyluracil.
    Kimura T; Chun YS; Ikeda M; Kobana K; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1997; (37):229-30. PubMed ID: 9586083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible existence of a novel receptor for uridine analogues in the central nervous system using two isomers, N3-(S)-(+)- and N3-(R)-(-)-alpha-hydroxy-beta-phenethyluridines.
    Kimura T; Miki M; Ikeda M; Yonemoto S; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Biol Pharm Bull; 2001 Jun; 24(6):729-31. PubMed ID: 11411572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypnotic activity of N3-benzylthymidine on mice.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    Life Sci; 1987 Dec; 41(26):2791-7. PubMed ID: 3695807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
    Lang TT; Selner M; Young JD; Cass CE
    Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N3-phenacyluridine as a new type of antinociceptive compound in mice.
    Kimura T; Shimizu T; Funahashi T; Nagakura M; Watanabe K; Tachibana K; Kondo S; Ho IK; Yamamoto I
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():57-65. PubMed ID: 15686107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central depressant activities of N3-allyluridine and N3-allylthymidine.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):321-32. PubMed ID: 3738212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypnotic action of N3-substituted arabinofuranosyluracils on mice.
    Kimura T; Yao S; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 2001 Jan; 49(1):111-3. PubMed ID: 11201214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and central nervous system depressant effects of N3-substituted 2',3'-O-isopropylideneuridines.
    Yao CS; Kimura T; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1802-4. PubMed ID: 10748724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.